Index
1 Market Overview of Genetic Virus Vector
1.1 Genetic Virus Vector Market Overview
1.1.1 Genetic Virus Vector Product Scope
1.1.2 Genetic Virus Vector Market Status and Outlook
1.2 Global Genetic Virus Vector Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Genetic Virus Vector Market Size by Region (2018-2029)
1.4 Global Genetic Virus Vector Historic Market Size by Region (2018-2023)
1.5 Global Genetic Virus Vector Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Genetic Virus Vector Market Size (2018-2029)
1.6.1 North America Genetic Virus Vector Market Size (2018-2029)
1.6.2 Europe Genetic Virus Vector Market Size (2018-2029)
1.6.3 Asia-Pacific Genetic Virus Vector Market Size (2018-2029)
1.6.4 Latin America Genetic Virus Vector Market Size (2018-2029)
1.6.5 Middle East & Africa Genetic Virus Vector Market Size (2018-2029)
2 Genetic Virus Vector Market by Type
2.1 Introduction
2.1.1 Retroviral Vectors
2.1.2 Adenoviral Vectors
2.1.3 Adeno-Associated Viral Vectors
2.1.4 Other
2.2 Global Genetic Virus Vector Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Genetic Virus Vector Historic Market Size by Type (2018-2023)
2.2.2 Global Genetic Virus Vector Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Genetic Virus Vector Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Genetic Virus Vector Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Genetic Virus Vector Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Genetic Virus Vector Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Genetic Virus Vector Revenue Breakdown by Type (2018-2029)
3 Genetic Virus Vector Market Overview by Application
3.1 Introduction
3.1.1 Gene Therapy
3.1.2 Vaccinology
3.2 Global Genetic Virus Vector Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Genetic Virus Vector Historic Market Size by Application (2018-2023)
3.2.2 Global Genetic Virus Vector Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Genetic Virus Vector Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Genetic Virus Vector Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Genetic Virus Vector Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Genetic Virus Vector Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Genetic Virus Vector Revenue Breakdown by Application (2018-2029)
4 Genetic Virus Vector Competition Analysis by Players
4.1 Global Genetic Virus Vector Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Genetic Virus Vector as of 2022)
4.3 Date of Key Players Enter into Genetic Virus Vector Market
4.4 Global Top Players Genetic Virus Vector Headquarters and Area Served
4.5 Key Players Genetic Virus Vector Product Solution and Service
4.6 Competitive Status
4.6.1 Genetic Virus Vector Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 FUJIFILM Diosynth Biotechnologies U.S.A.
5.1.1 FUJIFILM Diosynth Biotechnologies U.S.A. Profile
5.1.2 FUJIFILM Diosynth Biotechnologies U.S.A. Main Business
5.1.3 FUJIFILM Diosynth Biotechnologies U.S.A. Genetic Virus Vector Products, Services and Solutions
5.1.4 FUJIFILM Diosynth Biotechnologies U.S.A. Genetic Virus Vector Revenue (US$ Million) & (2018-2023)
5.1.5 FUJIFILM Diosynth Biotechnologies U.S.A. Recent Developments
5.2 Sanofi
5.2.1 Sanofi Profile
5.2.2 Sanofi Main Business
5.2.3 Sanofi Genetic Virus Vector Products, Services and Solutions
5.2.4 Sanofi Genetic Virus Vector Revenue (US$ Million) & (2018-2023)
5.2.5 Sanofi Recent Developments
5.3 Lonza
5.3.1 Lonza Profile
5.3.2 Lonza Main Business
5.3.3 Lonza Genetic Virus Vector Products, Services and Solutions
5.3.4 Lonza Genetic Virus Vector Revenue (US$ Million) & (2018-2023)
5.3.5 Merck KGaA Recent Developments
5.4 Merck KGaA
5.4.1 Merck KGaA Profile
5.4.2 Merck KGaA Main Business
5.4.3 Merck KGaA Genetic Virus Vector Products, Services and Solutions
5.4.4 Merck KGaA Genetic Virus Vector Revenue (US$ Million) & (2018-2023)
5.4.5 Merck KGaA Recent Developments
5.5 GENERAL ELECTRIC COMPANY
5.5.1 GENERAL ELECTRIC COMPANY Profile
5.5.2 GENERAL ELECTRIC COMPANY Main Business
5.5.3 GENERAL ELECTRIC COMPANY Genetic Virus Vector Products, Services and Solutions
5.5.4 GENERAL ELECTRIC COMPANY Genetic Virus Vector Revenue (US$ Million) & (2018-2023)
5.5.5 GENERAL ELECTRIC COMPANY Recent Developments
5.6 Oxford BioMedica
5.6.1 Oxford BioMedica Profile
5.6.2 Oxford BioMedica Main Business
5.6.3 Oxford BioMedica Genetic Virus Vector Products, Services and Solutions
5.6.4 Oxford BioMedica Genetic Virus Vector Revenue (US$ Million) & (2018-2023)
5.6.5 Oxford BioMedica Recent Developments
5.7 Spark Therapeutics, Inc.
5.7.1 Spark Therapeutics, Inc. Profile
5.7.2 Spark Therapeutics, Inc. Main Business
5.7.3 Spark Therapeutics, Inc. Genetic Virus Vector Products, Services and Solutions
5.7.4 Spark Therapeutics, Inc. Genetic Virus Vector Revenue (US$ Million) & (2018-2023)
5.7.5 Spark Therapeutics, Inc. Recent Developments
5.8 uniQure N.V.
5.8.1 uniQure N.V. Profile
5.8.2 uniQure N.V. Main Business
5.8.3 uniQure N.V. Genetic Virus Vector Products, Services and Solutions
5.8.4 uniQure N.V. Genetic Virus Vector Revenue (US$ Million) & (2018-2023)
5.8.5 uniQure N.V. Recent Developments
5.9 FinVector Vision Therapies
5.9.1 FinVector Vision Therapies Profile
5.9.2 FinVector Vision Therapies Main Business
5.9.3 FinVector Vision Therapies Genetic Virus Vector Products, Services and Solutions
5.9.4 FinVector Vision Therapies Genetic Virus Vector Revenue (US$ Million) & (2018-2023)
5.9.5 FinVector Vision Therapies Recent Developments
5.10 Brammer Bio
5.10.1 Brammer Bio Profile
5.10.2 Brammer Bio Main Business
5.10.3 Brammer Bio Genetic Virus Vector Products, Services and Solutions
5.10.4 Brammer Bio Genetic Virus Vector Revenue (US$ Million) & (2018-2023)
5.10.5 Brammer Bio Recent Developments
5.11 Cell and Gene Therapy Catapult
5.11.1 Cell and Gene Therapy Catapult Profile
5.11.2 Cell and Gene Therapy Catapult Main Business
5.11.3 Cell and Gene Therapy Catapult Genetic Virus Vector Products, Services and Solutions
5.11.4 Cell and Gene Therapy Catapult Genetic Virus Vector Revenue (US$ Million) & (2018-2023)
5.11.5 Cell and Gene Therapy Catapult Recent Developments
5.12 Cobra Biologics
5.12.1 Cobra Biologics Profile
5.12.2 Cobra Biologics Main Business
5.12.3 Cobra Biologics Genetic Virus Vector Products, Services and Solutions
5.12.4 Cobra Biologics Genetic Virus Vector Revenue (US$ Million) & (2018-2023)
5.12.5 Cobra Biologics Recent Developments
5.13 REGENXBIO Inc.
5.13.1 REGENXBIO Inc. Profile
5.13.2 REGENXBIO Inc. Main Business
5.13.3 REGENXBIO Inc. Genetic Virus Vector Products, Services and Solutions
5.13.4 REGENXBIO Inc. Genetic Virus Vector Revenue (US$ Million) & (2018-2023)
5.13.5 REGENXBIO Inc. Recent Developments
5.14 Kaneka Eurogentec S.A.
5.14.1 Kaneka Eurogentec S.A. Profile
5.14.2 Kaneka Eurogentec S.A. Main Business
5.14.3 Kaneka Eurogentec S.A. Genetic Virus Vector Products, Services and Solutions
5.14.4 Kaneka Eurogentec S.A. Genetic Virus Vector Revenue (US$ Million) & (2018-2023)
5.14.5 Kaneka Eurogentec S.A. Recent Developments
6 North America
6.1 North America Genetic Virus Vector Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Genetic Virus Vector Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Genetic Virus Vector Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Genetic Virus Vector Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Genetic Virus Vector Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Genetic Virus Vector Market Dynamics
11.1 Genetic Virus Vector Industry Trends
11.2 Genetic Virus Vector Market Drivers
11.3 Genetic Virus Vector Market Challenges
11.4 Genetic Virus Vector Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List